Participation in EP Suite Provides New Patient-Reported Outcomes Research Opportunity
Participating in the Electrophysiology (EP) Registry Suite can open doors to new research opportunities for your practice. The EP Registry Suite allows participating facilities to enroll in NCDR's AFib Ablation Registry and EP Device Implant Registry at a substantial discount, providing hospitals and health systems a fuller picture of their EP care and outcomes. Participation in the EP Device Implant Registry ensures facilities meet current CMS requirements for shared decision-making with ICD/CRT-D implantations, and allows hospitals to collect data on pacemaker and/or defibrillator procedures in one registry. And now, AFib Ablation Registry participants can offer for their patients to take part in VIBRANT-AF, a prospective, long-term study led by the University of California San Francisco (UCSF). By collecting repeated and real-time patient-recorded data with the EUREKA mobile app, the study seeks to identify clinically relevant predictors of effectiveness and complications of atrial fibrillation (AFib) procedures. With minimal effort, registry participants can link baseline NCDR data of study patients with longitudinal follow-up data. Learn more. For more information on the VIBRANT-AF research opportunity, attend an upcoming webinar hosted by Gregory Marcus, MD, MAS, from UCSF on Feb. 16 at noon ET. Register here.